Covera-HS treats high blood pressure and controls chest pain. Covera-HS can cause dizziness. Do not drive or operate heavy machinery until you know how Covera-HS affects you.

Covera-HS Overview


Covera-HS is a prescription medication used to treat chest pain, an irregular heartbeat, and high blood pressure. Covera-HS belongs to a group of drugs called calcium channel blockers, which work by relaxing the blood vessels, making it easier for the heart to pump blood.

Covera-HS is available as an extended-release tablet and is usually taken once a day with or without food. 

Common side effects of Covera-HS include constipation, nausea, low blood pressure, and headache. This medication can also cause dizziness. Do not drive or operate heavy machinery until you know how Covera-HS affects you.

This brand is no longer being manufactured.

How was your experience with Covera?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking Covera?

What are you taking Covera for?

Choose one
  • Other
  • Angina Pectoris, Variant
  • Hypertension
  • Myocardial Infarction
  • Tachycardia, Supraventricular

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did Covera work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend Covera to a friend?

Pill Images

{{ }}
pill-image {{ }}
Color: {{ slide.color }} Shape: {{ slide.shape }} Size: {{ slide.size }} Score: {{ slide.score }} Imprint: {{ slide.imprint }}
{{ slide.number }} of {{ }}

Covera-HS Cautionary Labels



Covera-HS Drug Class

Covera-HS is part of the drug class:


All RxWiki content including health news, medication pages, and condition pages published prior to February 2023, was written and maintained by on-staff pharmacists. Please be advised that this content is no longer actively maintained and may now contain outdated information. If you have any questions regarding previously published content, please contact